论文信息 - Transcriptomic FHITlow/pHER2high signature as a predictive factor of outcome and immunotherapy response in non-small cell lung cancer - 字舞流文

Transcriptomic FHITlow/pHER2high signature as a predictive factor of outcome and immunotherapy response in non-small cell lung cancer

M. Polette | G. Deslée | V. Dormoy | B. Nawrocki-Raby | A. Durlach | V. Dalstein | J. Ancel | Gonzagues Delepine | Adeline Germain | A. Brisebarre | Théophile Ponchel | Emma Loeffler | E. Loeffler